SG10202007867PA - Cancer epigenetic profiling - Google Patents

Cancer epigenetic profiling

Info

Publication number
SG10202007867PA
SG10202007867PA SG10202007867PA SG10202007867PA SG10202007867PA SG 10202007867P A SG10202007867P A SG 10202007867PA SG 10202007867P A SG10202007867P A SG 10202007867PA SG 10202007867P A SG10202007867P A SG 10202007867PA SG 10202007867P A SG10202007867P A SG 10202007867PA
Authority
SG
Singapore
Prior art keywords
epigenetic profiling
cancer
cancer epigenetic
profiling
epigenetic
Prior art date
Application number
SG10202007867PA
Inventor
Patrick Tan
Wen Fong Ooi
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG10202007867PA publication Critical patent/SG10202007867PA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875Nucleoproteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG10202007867PA 2016-02-16 2017-02-16 Cancer epigenetic profiling SG10202007867PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10201601141X 2016-02-16
SG10201606828P 2016-08-16

Publications (1)

Publication Number Publication Date
SG10202007867PA true SG10202007867PA (en) 2020-09-29

Family

ID=59625365

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10202007867PA SG10202007867PA (en) 2016-02-16 2017-02-16 Cancer epigenetic profiling
SG11201806945SA SG11201806945SA (en) 2016-02-16 2017-02-16 Cancer epigenetic profiling

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201806945SA SG11201806945SA (en) 2016-02-16 2017-02-16 Cancer epigenetic profiling

Country Status (7)

Country Link
US (1) US20210223249A1 (en)
EP (1) EP3417076B1 (en)
JP (2) JP7189020B2 (en)
KR (1) KR20180108820A (en)
CN (1) CN109072312A (en)
SG (2) SG10202007867PA (en)
WO (1) WO2017142485A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108085395A (en) * 2018-02-24 2018-05-29 韩林志 Primer sets, kit and the method for cervical carcinoma polygenes DNA methylation assay based on high-flux sequence
CN109735539B (en) * 2019-01-22 2022-06-03 南通大学 PDL1/PDL2 super-enhancer-based control method for regulating expression of PDL1 and PDL2
CN112111576A (en) * 2020-09-29 2020-12-22 杨帆 Method for screening nasopharyngeal carcinoma and application
CN114164210B (en) * 2021-08-19 2023-10-10 上海海洋大学 Long-chain non-coding RNA for regulating and controlling protooncogene MYB and application thereof
CN114525249A (en) * 2022-03-31 2022-05-24 广西大学 Muscle tissue extraction method for separating bovine muscle stem cells and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2470170A4 (en) * 2009-08-25 2013-01-02 Harvard College Use of metformin in cancer treatment and prevention
US20140287932A1 (en) 2012-10-25 2014-09-25 Whitehead Institute For Biomedical Research Super-enhancers and methods of use thereof
CN106103739B (en) * 2013-12-30 2019-12-06 新加坡科技研究局 Method for measuring biomarkers in gastrointestinal cancer
US20190005191A1 (en) * 2015-07-14 2019-01-03 Whitehead Institute For Biomedical Research Chromosome neighborhood structures and methods relating thereto

Also Published As

Publication number Publication date
JP7189020B2 (en) 2022-12-13
KR20180108820A (en) 2018-10-04
WO2017142485A1 (en) 2017-08-24
CN109072312A (en) 2018-12-21
JP2023029945A (en) 2023-03-07
EP3417076B1 (en) 2022-11-09
EP3417076A1 (en) 2018-12-26
EP3417076A4 (en) 2019-10-23
JP2019514344A (en) 2019-06-06
SG11201806945SA (en) 2018-09-27
US20210223249A1 (en) 2021-07-22

Similar Documents

Publication Publication Date Title
IL254283A0 (en) Molecular profiling for cancer
IL255217A0 (en) Cancer neoepitopes
IL254705B (en) Combination therapy for cancer
HUE038541T2 (en) Cancer treatments
IL277261A (en) Small molecules against cancer
HK1258319A1 (en) Cancer therapy
IL263802A (en) Cancer treatment combinations
IL263123A (en) Cancer treatments
SG10202007867PA (en) Cancer epigenetic profiling
GB201500584D0 (en) Cancer biomarkers
GB201618358D0 (en) Performance profiling
HK1251794A1 (en) Cancer treatment
GB201519734D0 (en) Cancer therapy
GB201508480D0 (en) Cancer
HK1254687A1 (en) Combination therapy for cancer
GB2546773B (en) Cancer
GB201522433D0 (en) Cancer treatment
HRP20210383T8 (en) Combination therapy for cancer
GB201703641D0 (en) Cancer biomarkers
GB201502840D0 (en) Cancer prognostic
GB201608972D0 (en) Polytape straightener
GB201604813D0 (en) Methods for detecting cancer
GB201522573D0 (en) Cancer therapeutics
GB201601248D0 (en) Cancer therapy
GB201514777D0 (en) Cancer Treatments